Propeller Health Flies to ResMed
And Propeller Health makes three. Three deals in 2018, that is, for ResMed Inc. (NYSE: RMD), which picked up Propeller for $225 million on December 3. ResMed is a global medical device maker with more than 6 million cloud-connected devices for daily remote patient monitoring for conditions like sleep apnea, chronic obstructive pulmonary disease (COPD) and other respiratory conditions. Propeller Health is a digital therapeutics company based in Madison, Wisconsin and backed by Aptar Pharma, Safeguard Scientifics, Social Capital, Hikma, 3M Ventures and SR One. Its products treat COPD patients in Stage 2 and 3 severity levels through connectivity, analytics and companion digital experiences.... Read More »
Aeroflow Healthcare Strikes Third Deal in 2018
Consolidation is happening all over the healthcare market, and one little-noticed area is the oxygen-therapy durable medical equipment providers. Aeroflow Healthcare, a home oxygen provider and leading durable medical equipment provider based in Asheville, North Carolina, announced its third deal of the year on December 4. The company is acquiring Wheelock Home Medical’s continuous positive airway pressure (CPAP) resupply program. The deal gives Aeroflow a foot into the Michigan medical device market. CPAP supplies can deteriorate and leak air, and Aeroflow will be able to resupply those devices to ensure effective treatment. In November, Aeroflow purchased a positive airway pressure... Read More »
How Moved My Turkey? November Deals Drop 26%
Calm down. So deal volume plummetted 26%, to a mere 136 deals compared with October’s 183 (that’s a monthly record, by the way). November is typically a slower month for deal making, what with a four-day Thanksgiving holiday diverting attention away from healthcare transactions. This November’s deal volume bested last year’s results by 24% (110 deals), at least. This is still the fourth quarter, after all, and December 31st is looming on the horizon. We expect to see some late-in-the-month action move the quarter’s goal posts toward higher ground. Last year’s fourth quarter ended with 396 transactions, virtually dead even with Q4:16’s 397 deals. We’ll likely beat those totals in 2018.... Read More »
Medtronic Adds AI Component to its Diabetes Group
It’s been some time since Medtronic plc (NYSE: MDT) added outside capabilities to its Diabetes Group. Since 2015, in fact, when it bought Diabeter, an independent clinic and research center in Rotterdam. Now the medical device maker has added Nutrino Health, an Israeli digital health company focused on nutrition. It provides nutrition-related data services, analytics and technologies using artificial intelligence-driven personal assessments. It also has been developing algorithms to predict glycemic responses to food. In April 2018, Nutrino raised $8 million in a Series A round from Pereg Ventures, Nielsen Ventures, Gandyr Group and a number of business angels. Financial terms of its... Read More »
After a Drought, Medical Device Deals Are on the Rise
The medical device market is making a comeback in 2018, after several years of steady but uninspiring performance. Through the end of October, 103 transactions have been announced. That’s still below last year’s total, but there are two months to go in the year. Deal volume in the third quarter reached 41 transactions, up 32% compared with the previous quarter and up 78% over the year-ago period. This quarter’s deals account for 34% of the 122 deals announced in the previous 12 months. Annual deal volume hit a peak of 194 transactions in 2007, and stayed well above 165 deals per year through 2011 (175 transactions). In 2012, mergers and acquisitions topped out at 145... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
